Expand AXSM Menu
AXSM MENU

AXSM Latest Press Releases

-- November 20, 2025 --

Axsome Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM

-- November 10, 2025 --

Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Axsome Therapeutics, Inc. Common Stock - AXSM Globe Newswire 9:00 AM

-- November 6, 2025 --

Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy Globe Newswire 7:00 AM
Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics Globe Newswire 7:00 AM

-- November 3, 2025 --

Axsome Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update Globe Newswire 7:00 AM

-- October 24, 2025 --

Halper Sadeh LLC Encourages Axsome Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights Business Wire 11:20 AM

-- October 22, 2025 --

Axsome Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM

-- October 9, 2025 --

Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community Globe Newswire 7:00 AM

-- October 7, 2025 --

Axsome Therapeutics to Report Third Quarter 2025 Financial Results on November 3 Globe Newswire 7:00 AM

-- September 17, 2025 --

Axsome Therapeutics Highlights Data Across Its Leading Neuroscience Pipeline at Psych Congress 2025 Globe Newswire 7:00 AM

-- September 12, 2025 --

Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Este Lauder, and Axsome Therapeutics Survive Motions to Dismiss - Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm Globe Newswire 8:12 PM

-- August 27, 2025 --

Axsome Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM

-- August 4, 2025 --

Axsome Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update Globe Newswire 7:00 AM

-- July 21, 2025 --

Axsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS Pipeline Globe Newswire 7:30 AM
Axsome Therapeutics to Ring the NASDAQ Stock Market Opening Bell Today Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes